BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34237623)

  • 1. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells.
    Wang CJ; Guo X; Zhai RQ; Sun C; Xiao G; Chen J; Wei MY; Shao CL; Gu Y
    Eur J Med Chem; 2021 Nov; 224():113671. PubMed ID: 34237623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
    Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
    Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma.
    Eissa IH; Ibrahim MK; Metwaly AM; Belal A; Mehany ABM; Abdelhady AA; Elhendawy MA; Radwan MM; ElSohly MA; Mahdy HA
    Bioorg Chem; 2021 Feb; 107():104532. PubMed ID: 33334586
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Huang XF; Sheu GT; Chang KF; Huang YC; Hung PH; Tsai NM
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33266043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition.
    Yang H; Li Q; Su M; Luo F; Liu Y; Wang D; Fan Y
    Bioorg Med Chem; 2021 Sep; 46():116346. PubMed ID: 34403956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New brefeldin A-cinnamic acid ester derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
    Jiang YY; Wu S; Wu YW; Gao Y; Chong D; Sun C; Wei MY; Gu YC; Shao CL; Gu Y
    Eur J Med Chem; 2022 Oct; 240():114598. PubMed ID: 35849940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
    Harras MF; Sabour R
    Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
    Huo S; Yu H; Li C; Zhang J; Liu T
    Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
    Ahmed NM; Youns M; Soltan MK; Said AM
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
    Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.
    Zheng S; Chang S; Lu J; Chen Z; Xie L; Nie Y; He B; Zou S; Gu Z
    PLoS One; 2011; 6(6):e21064. PubMed ID: 21695227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity.
    Bian M; Wang X; Sun Y; Liu W
    Eur J Med Chem; 2020 May; 193():112234. PubMed ID: 32213395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
    Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
    Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
    Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
    Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma.
    Mohamady S; Ismail MI; Mogheith SM; Attia YM; Taylor SD
    Bioorg Chem; 2020 Jan; 94():103433. PubMed ID: 31785857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluations of N'-substituted methylene-4-(quinoline-4-amino) benzoylhydrazides as potential anti-hepatoma agents.
    Li B; Zhu F; He F; Huang Q; Liu X; Wu T; Zhao T; Qiu Y; Wu Z; Xue Y; Fang M
    Bioorg Chem; 2020 Mar; 96():103592. PubMed ID: 32044517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quinazoline derivative, 04NB-03, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells in a reactive oxygen species-dependent manner.
    Wang R; Zhu Y; Chen J; Wang Y; Song X; Wu Y; Jin F; Wang Y
    Chem Biol Interact; 2021 Apr; 338():109371. PubMed ID: 33582112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α.
    Kim SM; Han JM; Le TT; Sohng JK; Jung HJ
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
    Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
    Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.